However, increased tissue expression due to other pathological conditions than muscular dystrophy, such as aging (Staunton et al, 2012), obesity and treatment with insulin or leptin (Alver et al, 2004), might affect serum levels of CA3. This evidence concerns the gene INS and obesity disorder.